Imagine a technology capable of identifying 'fresh' blood clots in real time within patients suffering from peripheral artery disease (PAD), promising to revolutionize treatment and patient outcomes. This is precisely what Sensome's Clotild Smart Guidewire System aims to achieve,
The recent FDA approval of Johnson & Johnson (J&J) MedTech’s Impella 5.5 with SmartAssist and Impella CP with SmartAssist heart pumps for pediatric use marks a significant milestone in pediatric cardiac care. This development opens new avenues for treating children with acute decompensated h
Randomization in clinical trials is essential for reducing selection bias among participants and ensuring robust and reliable results. Solventum, a leading medical device company, has revolutionized this vital process by utilizing the Zelta by Merative eClinical platform, introducing an innovative
FemPulse has recently achieved a significant milestone by obtaining an investigational device exemption (IDE) from the US Food and Drug Administration (FDA). This approval allows the company to conduct a pivotal clinical trial for its neuromodulation system designed to treat overactive bladder
The National Institutes of Health (NIH) remains the primary federal agency responsible for conducting and supporting medical research in the United States. It allocates research funding through various mechanisms, with the study section peer review system being one of the key methods. This system
In a groundbreaking study conducted by researchers at the Peter Doherty Institute for Infection and Immunity, a significant discovery has been made, revealing a novel mechanism by which the body regulates a type of immune cell known as unconventional T cells. These cells are pivotal in mounting